iifl-logo-icon 1

Bliss GVS Pharma Ltd Share Price

114.07
(-1.66%)
Jul 16, 2024|03:32:48 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open117.44
  • Day's High117.44
  • 52 Wk High149.6
  • Prev. Close115.99
  • Day's Low113.51
  • 52 Wk Low77.35
  • Turnover (lac)294.54
  • P/E15.96
  • Face Value1
  • Book Value94.37
  • EPS7.27
  • Mkt. Cap (Cr.)1,194.74
  • Div. Yield0.43
No Records Found

Bliss GVS Pharma Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

117.44

Prev. Close

115.99

Turnover(Lac.)

294.54

Day's High

117.44

Day's Low

113.51

52 Week's High

149.6

52 Week's Low

77.35

Book Value

94.37

Face Value

1

Mkt Cap (₹ Cr.)

1,194.74

P/E

15.96

EPS

7.27

Divi. Yield

0.43

Bliss GVS Pharma Ltd Corporate Action

12 May 2023

12:00 AM

AGM

Announcement Date: 12 May, 2023

arrow

11 May 2023

12:00 AM

Dividend

Dividend Amount: 0.5

arrow

25 Apr 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

12 May 2023

12:00 AM

BookCloser

arrow

Bliss GVS Pharma Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Bliss GVS Pharma Ltd SHAREHOLDING SNAPSHOT

16 Jul, 2024|02:26 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 34.96%

Foreign: 0.00%

Indian: 34.96%

Non-Promoter- 21.32%

Institutions: 21.32%

Non-Institutions: 43.70%

Custodian: 0.00%

Share Price

Bliss GVS Pharma Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

10.51

10.42

10.37

10.31

Preference Capital

0

0

0

0

Reserves

977.94

926.58

841.06

745.33

Net Worth

988.45

937

851.43

755.64

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2019

Revenue

636.35

465.51

441.95

426.59

yoy growth (%)

36.7

5.33

3.6

43.2

Raw materials

-343.94

-253.3

-236.72

-225.14

As % of sales

54.04

54.41

53.56

52.77

Employee costs

-65.05

-58.6

-44.02

-33.84

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2019

Profit before tax

123.65

91.18

121.71

120.01

Depreciation

-13.84

-13.76

-8.83

-5.74

Tax paid

-33.73

-23.68

-29.37

-45.57

Working capital

73.23

16.34

44.64

-0.64

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2019

Growth matrix (%)

Revenue growth

36.7

5.33

3.6

43.2

Op profit growth

19.39

-8.69

7.58

5.23

EBIT growth

34.17

-24.46

2.52

31.32

Net profit growth

37.27

-26.89

24.04

30.55

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

770.24

751.59

747.45

577.21

689.31

Excise Duty

0

0

0

0

0

Net Sales

770.24

751.59

747.45

577.21

689.31

Other Operating Income

0

0

0

0

0

Other Income

28.74

17.79

31.49

20.22

39.19

Bliss GVS Pharma Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,586.2

124.663,80,450.55867.60.855,536.9998.75

Cipla Ltd

CIPLA

1,517.2

32.961,22,423.771,038.40.563,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,575.4

77.071,21,461.175310.652,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,188

34.771,19,530.541,405.20.253,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,794.75

26.451,13,324.081,034.80.595,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Bliss GVS Pharma Ltd

Management

Register Office

Registrar Office

Whole-time Director

Vibha G Sharma

Whole-time Director

Shruti Vishal Rao

Chairman & Independent Directo

Subramanian R Vaidya

Non-Exec. & Independent Dir.

Santosh Parab

Company Sec. & Compli. Officer

Aditi Bhatt

Non-Exec. & Independent Dir.

Shilpa Bhatia

Managing Director

Gagan Harsh Sharmma

Independent Director

Nandkumar Kashinath Chodankar

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Bliss GVS Pharma Ltd is an export-oriented pharmaceutical company. It is among the world leaders in Suppositories and Pessaries dosage forms with one of the largest portfolios in this segment. Bliss GVS Pharma has presence in antimalarial, antifungal, antibacterial, anti-inflammatory and antibiotic therapeutic segments. It is a leading player in the antimalarial branded formulations segment. Bliss GVS Pharma is the only EU-GMP certified suppositories manufacturer in India.The company has a dedicated the R&D Centre for development of Suppositories, Semi Solids and Oral Solids with an experienced Team of over 50 Scientists for formulation development and analytical method development and certified by the Department of Scientific & Industrial Research (DSIR), Government of India.Incorporated in 1984 as a private limited company under the name Bliss Chemicals & Pharmaceuticals India Ltd, the company commenced its business in 1985. In 1994 the company introduced a new pharmaceutical product VAGID.During the financial year ended 31 March 2014, Bliss GVS Pharmas R&D center, received approval from Government of Indias Department for Scientific & Industrial Research (DSIR).During the year under review, the company invested in 51% share capital of Lifeon Labs Pvt Ltd. During the year under review, Bliss GVS Pharma faced challenges in Ghana, where delays in registration resulted in adverse regulatory action. However, the company took quick, corrective measures to resolve these issues. T
Read More

Company FAQs

What is the Bliss GVS Pharma Ltd share price today?

Down Arrow

The Bliss GVS Pharma Ltd shares price on N/A is Rs.₹114.65 today.

What is the Market Cap of Bliss GVS Pharma Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Bliss GVS Pharma Ltd is ₹1200.82 Cr. as of 16 Jul ‘24

What is the PE and PB ratio of Bliss GVS Pharma Ltd?

Down Arrow

The PE and PB ratios of Bliss GVS Pharma Ltd is 15.96 and 1.23 as of 16 Jul ‘24

What is the 52 Week High and Low of Bliss GVS Pharma Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Bliss GVS Pharma Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Bliss GVS Pharma Ltd is ₹77.65 and ₹148.95 as of 16 Jul ‘24

What is the CAGR of Bliss GVS Pharma Ltd?

Down Arrow

Bliss GVS Pharma Ltd's CAGR for 5 Years at -6.00%, 3 Years at 1.04%, 1 Year at 15.34%, 6 Month at -11.95%, 3 Month at 5.31% and 1 Month at 11.97%.

What is the shareholding pattern of Bliss GVS Pharma Ltd?

Down Arrow

The shareholding pattern of Bliss GVS Pharma Ltd is as follows:
Promoters - 34.97 %
Institutions - 21.33 %
Public - 43.71 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.